-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 AHD+WxGOX0cBgsEzA2AZJYDLD0HvCHVWb0LlEyE+OF6eTTV3FKBo7v2/m6YsFUF8
 LMOMhuGXMyeWrDXiO/on1Q==

<SEC-DOCUMENT>0001055947-03-000030.txt : 20031107
<SEC-HEADER>0001055947-03-000030.hdr.sgml : 20031107
<ACCEPTANCE-DATETIME>20031107174635
ACCESSION NUMBER:		0001055947-03-000030
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20031105
FILED AS OF DATE:		20031107

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			BVF INC/IL
		CENTRAL INDEX KEY:			0001056807

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-16633
		FILM NUMBER:		03986346

	BUSINESS ADDRESS:	
		STREET 1:		227 WEST MONROE STE
		STREET 2:		STE 4800
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606
		BUSINESS PHONE:		3122637777

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ARRAY BIOPHARMA INC
		CENTRAL INDEX KEY:			0001100412
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				841460811
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	BUSINESS ADDRESS:	
		STREET 1:		1885 33RD ST
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301
		BUSINESS PHONE:		3033816600

	MAIL ADDRESS:	
		STREET 1:		1885 33RD STREET
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			BIOTECHNOLOGY VALUE FUND II LP
		CENTRAL INDEX KEY:			0001102444
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-16633
		FILM NUMBER:		03986348

	BUSINESS ADDRESS:	
		STREET 1:		ONE SANSOME ST
		STREET 2:		39TH FL.
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104
		BUSINESS PHONE:		3122637777

	MAIL ADDRESS:	
		STREET 1:		C/O GROSVENOR CAPITAL MANAGEMENT
		STREET 2:		227 W. MONROE ST #4800
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			BIOTECHNOLOGY VALUE FUND L P
		CENTRAL INDEX KEY:			0000918923
		STANDARD INDUSTRIAL CLASSIFICATION:	INVESTMENT ADVICE [6282]
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-16633
		FILM NUMBER:		03986349

	BUSINESS ADDRESS:	
		STREET 1:		227 W MONROE STREET, SUITE 4800
		STREET 2:		227 W MONROE STREET, SUITE 4800
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606
		BUSINESS PHONE:		415-288-23

	MAIL ADDRESS:	
		STREET 1:		227 W MONROE STREET, SUITE 4800
		STREET 2:		227 W MONROE STREET, SUITE 4800
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			BVF INVESTMENTS LLC
		CENTRAL INDEX KEY:			0001132245
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-16633
		FILM NUMBER:		03986347

	BUSINESS ADDRESS:	
		STREET 1:		ONE SANSOME ST. 39TH FL
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104
		BUSINESS PHONE:		3127392123

	MAIL ADDRESS:	
		STREET 1:		C/O GROSVENOR CAPITAL MANAGEMENT LP
		STREET 2:		227 W. MONROE ST. #4800
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			BVF PARTNERS L P/IL
		CENTRAL INDEX KEY:			0001055947

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-16633
		FILM NUMBER:		03986350

	BUSINESS ADDRESS:	
		STREET 1:		ONE SANSOME ST
		STREET 2:		39TH FL
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104
		BUSINESS PHONE:		3122637777

	MAIL ADDRESS:	
		STREET 1:		227 W MONROE
		STREET 2:		SUITE 4800
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>edgar.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>
    <schemaVersion>X0201</schemaVersion>

    <documentType>4</documentType><periodOfReport>2003-11-05</periodOfReport><notSubjectToSection16>1</notSubjectToSection16>
    <issuer>
        <issuerCik>0001100412</issuerCik>
        <issuerName>ARRAY BIOPHARMA INC</issuerName>
        <issuerTradingSymbol>ARRY</issuerTradingSymbol></issuer><reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001055947</rptOwnerCik>
            <rptOwnerName>BVF PARTNERS L P/IL</rptOwnerName>
        </reportingOwnerId>
<reportingOwnerAddress><rptOwnerStreet1>227 West Monroe Street, Suite 4800</rptOwnerStreet1><rptOwnerStreet2/><rptOwnerCity>Chicago</rptOwnerCity><rptOwnerState>IL</rptOwnerState><rptOwnerZipCode>60606</rptOwnerZipCode></reportingOwnerAddress><reportingOwnerRelationship><isDirector>0</isDirector><isOfficer>0</isOfficer><isTenPercentOwner>1</isTenPercentOwner><isOther>1</isOther><otherText>Indirect Beneficial Owner</otherText></reportingOwnerRelationship></reportingOwner><reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0000918923</rptOwnerCik>
            <rptOwnerName>BIOTECHNOLOGY VALUE FUND L P</rptOwnerName>
        </reportingOwnerId>
<reportingOwnerAddress><rptOwnerStreet1>227 West Monroe Street, Suite 4800</rptOwnerStreet1><rptOwnerStreet2/><rptOwnerCity>Chicago</rptOwnerCity><rptOwnerState>IL</rptOwnerState><rptOwnerZipCode>60606</rptOwnerZipCode></reportingOwnerAddress><reportingOwnerRelationship><isDirector>0</isDirector><isOfficer>0</isOfficer><isTenPercentOwner>0</isTenPercentOwner><isOther>1</isOther><otherText> Direct Beneficial Owner</otherText></reportingOwnerRelationship></reportingOwner><reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001102444</rptOwnerCik>
            <rptOwnerName>BIOTECHNOLOGY VALUE FUND II LP</rptOwnerName>
        </reportingOwnerId>
<reportingOwnerAddress><rptOwnerStreet1>227 West Monroe Street, Suite 4800</rptOwnerStreet1><rptOwnerStreet2/><rptOwnerCity>Chicago</rptOwnerCity><rptOwnerState>IL</rptOwnerState><rptOwnerZipCode>60606</rptOwnerZipCode></reportingOwnerAddress><reportingOwnerRelationship><isDirector>0</isDirector><isOfficer>0</isOfficer><isTenPercentOwner>0</isTenPercentOwner><isOther>1</isOther><otherText>  Direct Beneficial Owner</otherText></reportingOwnerRelationship></reportingOwner><reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001132245</rptOwnerCik>
            <rptOwnerName>BVF INVESTMENTS LLC</rptOwnerName>
        </reportingOwnerId>
<reportingOwnerAddress><rptOwnerStreet1>227 West Monroe Street, Suite 4800</rptOwnerStreet1><rptOwnerStreet2/><rptOwnerCity>Chicago</rptOwnerCity><rptOwnerState>IL</rptOwnerState><rptOwnerZipCode>60606</rptOwnerZipCode></reportingOwnerAddress><reportingOwnerRelationship><isDirector>0</isDirector><isOfficer>0</isOfficer><isTenPercentOwner>0</isTenPercentOwner><isOther>1</isOther><otherText>  Direct Beneficial Owner</otherText></reportingOwnerRelationship></reportingOwner><reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001056807</rptOwnerCik>
            <rptOwnerName>BVF INC/IL</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>ONE SANSOME STREET, 31ST FLOOR</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>SAN FRANCISCO</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>94104</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
            <reportingOwnerRelationship>
<isDirector>0</isDirector><isOfficer>0</isOfficer><isTenPercentOwner>1</isTenPercentOwner><isOther>1</isOther><otherText>Indirect Beneficial Owner</otherText></reportingOwnerRelationship></reportingOwner><nonDerivativeTable><nonDerivativeTransaction><securityTitle><value>Common Stock</value></securityTitle><transactionDate><value>2003-11-05</value></transactionDate><transactionCoding><transactionFormType>4</transactionFormType><transactionCode>S</transactionCode><equitySwapInvolved>0</equitySwapInvolved></transactionCoding><transactionAmounts><transactionShares><value>1249985</value><footnoteId id="F3"/></transactionShares><transactionPricePerShare><value>5.00</value></transactionPricePerShare><transactionAcquiredDisposedCode><value>D</value></transactionAcquiredDisposedCode></transactionAmounts><postTransactionAmounts><sharesOwnedFollowingTransaction><value>2615050</value><footnoteId id="F6"/></sharesOwnedFollowingTransaction></postTransactionAmounts><ownershipNature><directOrIndirectOwnership><value>I</val
ue></directOrIndirectOwnership><natureOfOwnership><value>See footnotes </value><footnoteId id="F1"/><footnoteId id="F2"/></natureOfOwnership></ownershipNature></nonDerivativeTransaction><nonDerivativeTransaction><securityTitle><value>Common Stock</value></securityTitle><transactionDate><value>2003-11-05</value></transactionDate><transactionCoding><transactionFormType>4</transactionFormType><transactionCode>S</transactionCode><equitySwapInvolved>0</equitySwapInvolved></transactionCoding><transactionAmounts><transactionShares><value>706450</value><footnoteId id="F4"/></transactionShares><transactionPricePerShare><value>5.00</value></transactionPricePerShare><transactionAcquiredDisposedCode><value>D</value></transactionAcquiredDisposedCode></transactionAmounts><postTransactionAmounts><sharesOwnedFollowingTransaction><value>1908600</value><footnoteId id="F6"/></sharesOwnedFollowingTransaction></postTransactionAmounts><ownershipNature><directOrIndirectOwnership><value>I</value></directOrIndirectOwnership><natureO
fOwnership><value>See footnotes </value><footnoteId id="F1"/><footnoteId id="F2"/></natureOfOwnership></ownershipNature></nonDerivativeTransaction><nonDerivativeTransaction><securityTitle><value>Common Stock</value></securityTitle><transactionDate><value>2003-11-05</value></transactionDate><transactionCoding><transactionFormType>4</transactionFormType><transactionCode>S</transactionCode><equitySwapInvolved>0</equitySwapInvolved></transactionCoding><transactionAmounts><transactionShares><value>1908600</value><footnoteId id="F5"/></transactionShares><transactionPricePerShare><value>5.00</value></transactionPricePerShare><transactionAcquiredDisposedCode><value>D</value></transactionAcquiredDisposedCode></transactionAmounts><postTransactionAmounts><sharesOwnedFollowingTransaction><value>0</value><footnoteId id="F6"/></sharesOwnedFollowingTransaction></postTransactionAmounts><ownershipNature><directOrIndirectOwnership><value>I</value></directOrIndirectOwnership><natureOfOwnership><value>See footnotes </value><foo
tnoteId id="F1"/><footnoteId id="F2"/></natureOfOwnership></ownershipNature></nonDerivativeTransaction></nonDerivativeTable><footnotes><footnote id="F1">The shares reported in this response are indirectly beneficially owned by BVF Partners L.P., a Delaware limited partnership (&quot;Partners&quot;), the designated filer of this joint filing on Form 4, and by its general partner, BVF Inc., a Delaware corporation (&quot;BVF Inc.&quot;), which is also an investment advisor to Partners. Partners is the general partner of Biotechnology Value Fund, L.P., a Delaware limited partnership (&quot;BVF, L.P.&quot;) and Biotechnology Value Fund II, L.P., a Delaware limited partnership (&quot;BVF2, L.P.&quot;), both investment limited partnerships. Partners also is the manager of BVF Investments, L.L.C., a Delaware limited liability company (&quot;Investments&quot;). Pursuant to the operating agreement of Investments, Partners is authorized, among other things, to invest the funds of Ziff Asset Management, L.P., the majori
ty member of Investments, in the shares of Common Stock reported in Table I as being beneficially owned by Investments. </footnote><footnote id="F2">Mark N. Lampert is the sole shareholder and sole director of BVF Inc., and is an officer of BVF Inc. This joint filing on Form 4 shall not be deemed an admission that Mark N. Lampert is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the beneficial owner of any equity securities covered by this joint filing.</footnote><footnote id="F3">Shares directly beneficially owned by BVF, L.P.</footnote><footnote id="F4">Shares directly beneficially owned by BVF2, L.P.</footnote><footnote id="F5">Shares directly beneficially owned by Investments</footnote><footnote id="F6">Total amount of shares indirectly beneficially owned by Partners and BVF Inc.</footnote></footnotes><remarks/><ownerSignature><signatureName>BVF Partners L.P., By: BVF Inc., its GP, By: /s/ Mark N. Lampert</signatureName><signatureDate>2003-11-07</signatureDa
te></ownerSignature><ownerSignature><signatureName>BIOTECHNOLOGY VALUE FUND, L.P. By: BVF Partners L.P., its GP, By: BVF Inc., By: /s/ Mark N. Lampert</signatureName><signatureDate>2003-11-07</signatureDate></ownerSignature><ownerSignature><signatureName>BIOTECHNOLOGY VALUE FUND II, L.P., By: BVF Partners L.P., its GP, By: BVF Inc., By: /s/ Mark N. Lampert</signatureName><signatureDate>2003-11-07</signatureDate></ownerSignature><ownerSignature><signatureName>BVF INVESTMENTS, L.L.C., By: BVF Partners L.P., its Manager, By: BVF Inc., By: /s/ Mark N. Lampert</signatureName><signatureDate>2003-11-07</signatureDate></ownerSignature><ownerSignature><signatureName>BVF INC., By: /s/ Mark N. Lampert</signatureName><signatureDate>2003-11-07</signatureDate></ownerSignature></ownershipDocument>

</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----